1A |
Clear |
Randomised controlled trials without important limitations |
Strong recommendation; can apply to most patients in most circumstances without reservation |
1C+ |
Clear |
No randomised controlled trials but strong results from randomised controlled trials can be unequivocally extrapolated, or overwhelming evidence from observational studies |
Strong recommendation; can apply to most patients in most circumstances |
1B |
Clear |
Randomised controlled trials with important limitations (inconsistent results, methodological flaws) |
Strong recommendations; likely to apply to most patients |
1C |
Clear |
Observational studies |
Intermediate-strength recommendation; may change when stronger evidence is available |
2A |
Unclear |
Randomised controlled trials without important limitations |
Intermediate-strength recommendation; best action may differ depending on circumstances or patients’ or societal values |
2C+ |
Unclear |
No randomised controlled trials but strong results from randomised controlled trials can be unequivocally extrapolated, or overwhelming evidence from observational studies |
Weak recommendation; best action may differ depending on circumstances or patients’ or societal values |
2B |
Unclear |
Randomised controlled trials with important limitations (inconsistent results, methodological flaws) |
Weak recommendation; alternative approaches likely to be better for some patients under some circumstances |
2C |
Unclear |
Evidence obtained from respected authorities or from expert committee reports or opinion of the group of experts responsible for these recommendations |
Very weak recommendations; other alternatives may be equally reasonable |